Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01866319 |
|---|---|
| Brief Title: | Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006) |
| First Submitted : | May 28, 2013 |
| First Submitted that Met QC Criteria : | May 28, 2013 |
| First Posted : | May 31, 2013 (Estimate) |
| Results First Submitted : | December 9, 2015 |
| Results First Submitted that Met QC Criteria : | December 9, 2015 |
| Results First Posted : | January 14, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 22, 2020 |
| Last Update Posted : | June 2, 2020 |